Metal complexes synthesis and properties

Platinum-based drugs like cisplatin have been cornerstones of cancer chemotherapy for decades, working by binding to DNA and triggering cell death, yet their usefulness is limited by acquired drug resistance and significant toxicity in healthy tissue. Chemists and biologists working at this intersection study exactly how metal compounds interact with DNA and other cellular targets at the molecular level, tracing the pathways by which tumors learn to evade or neutralize these drugs. A central open question is whether other metals — ruthenium in particular — can be designed into complexes that retain or improve on platinum's anticancer potency while circumventing the resistance mechanisms that make long-term platinum therapy so difficult. Mapping those molecular mechanisms precisely enough to guide rational drug design remains one of the field's most active and consequential challenges.

Works

146,509

Total citations

2,306,790

Keywords

Platinum-Based DrugsCisplatin ResistanceMetal ComplexesAnticancer AgentsMolecular MechanismsDNA Interactions